Translation of orofacial sciences (translational research, education)
Following graduation from the University of Otago (New Zealand) as a dentist, Mike did a PhD in Biochemistry (Otago), spent a year in private dental practice, then undertook postdoctoral positions investigating calcium signalling with Claude Klee (National Cancer Institute, NIH, USA) and protein phosphorylation with Sir Philip Cohen (University of Dundee, Scotland). On return to Otago in 1990, he established his independent research career, focusing on the cells that form dental enamel.
In 2003, Mike shifted camp to Melbourne where he currently works in the Paediatrics and Pharmacology Departments under auspice of the Melbourne Research Unit for Facial Disorders. His overall mission is to promote translational research and education in the oral and facial sciences, with a focus on prevalent tooth and bone problems.
New Translational Initiatives
Since 2003, Mike has spear-headed development of the Melbourne Research Unit for Facial Disorders (MRUFD) into an effective translational research unit with active fronts in oral health and biomedical technology, and two network-group spin-outs as follows.
First, he instigated a cross-sector technology network, now known as Proteomics & Metabolomics Victoria
. This initiative has strengthened the sector through several key improvements (unity, technology access, communication, education, strategy & advocacy).
Second, he instigated The D3 Group
, a cross-sector network focused on Developmental Dental Defects (DDD=D3
), which are popularly known as "chalky teeth". This Australia+NZ network brings together a broad community (researchers, clinicians, public health, industry & affected families) with the mission to improve understanding and care of people with chalky teeth (D3s). In 2013 Mike launched a comprehensive online-educat
Editorial Board, Current Proteomics.
Board member 2007 -